We are live on
!
Find out more
WC
Wexford Capital Portfolio holdings
AUM
$690M
1-Year Est. Return
57.92%
This Fund
S&P 500
This Quarter
Est. Return
+18.55%
1 Year Est. Return
+57.92%
3 Year Est. Return
+92.61%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.17B
AUM Growth
-$42.8M
(-3.5%)
Cap. Flow
-$200M
Cap. Flow
% of AUM
-17.09%
Top 10 Holdings %
Top 10 Hldgs %
63.83%
Holding
315
New
118
Increased
30
Reduced
60
Closed
98
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
American Airlines Group
AAL
|
+$22.9M |
| 2 |
AGN
Allergan plc
AGN
|
+$9.42M |
| 3 |
Mohawk Industries
MHK
|
+$7.87M |
| 4 |
Amgen
AMGN
|
+$7.31M |
| 5 |
AGN
Allergan Inc
AGN
|
+$6.66M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Diamondback Energy
FANG
|
+$56.6M |
| 2 |
ONXX
ONYX PHARMACEUTICALS INC
ONXX
|
+$31.6M |
| 3 |
CLR
CONTINENTAL RESOURCES INC.
CLR
|
+$15.6M |
| 4 |
Gilead Sciences
GILD
|
+$15.4M |
| 5 |
EOG Resources
EOG
|
+$14.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 60.8% |
| 2 | Healthcare | 8.63% |
| 3 | Consumer Discretionary | 7.28% |
| 4 | Industrials | 7.26% |
| 5 | Technology | 2.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Diamondback Energy
FANG
$57.8B
| $563M | 48.14% |
10,640,602
-1,139,334
| -10% | -$56.6M |
|
|
RNO
2
DELISTED
RHINO RESOURCE PARTNERS LP COM UNIT REPSTG LTD (DE)
RNO
| $75.5M | 6.46% |
6,632,176
+2,540
| +0% | +$30.4K |
|
|
3
American Airlines Group
AAL
$8.96B
| $22.4M | 1.92% |
+889,086
| New | +$22.9M |
|
|
PVA
4
DELISTED
PENN VIRGINIA CORP
PVA
| $17.9M | 1.53% |
1,898,723
+681,453
| +56% | +$6.18M |
|
5
Delta Air Lines
DAL
$53.9B
| $12.4M | 1.06% |
452,370
+129,800
| +40% | +$3.49M |
|
|
S
6
DELISTED
Sprint Corporation
S
| $12.4M | 1.06% |
1,154,211
-757,930
| -40% | -$5.71M |
|
|
AGN
7
DELISTED
Allergan plc
AGN
| $11.1M | 0.95% |
66,247
+60,247
| +1,004% | +$9.42M |
|
8
General Motors
GM
$73B
| $10.8M | 0.92% |
263,590
+173,590
| +193% | +$6.56M |
|
|
RPRX
9
DELISTED
Repros Therapeutics Inc.
RPRX
| $10.5M | 0.9% |
575,131
-649,299
| -53% | -$12.3M |
|
10
Micron Technology
MU
$1.12T
| $10.3M | 0.88% |
472,270
-368,530
| -44% | -$7.16M |
|
|
MDCO
11
DELISTED
Medicines Co
MDCO
| $10.1M | 0.87% |
262,600
-193,900
| -42% | -$6.93M |
|
|
AGN
12
DELISTED
Allergan Inc
AGN
| $9.97M | 0.85% |
89,730
+69,730
| +349% | +$6.66M |
|
|
13
Amgen
AMGN
$201B
| $8.6M | 0.74% |
75,394
+64,284
| +579% | +$7.31M |
|
|
14
Mohawk Industries
MHK
$6.71B
| $8.58M | 0.73% |
+57,640
| New | +$7.87M |
|
15
AerCap
AER
$23.4B
| $7.89M | 0.67% |
205,624
-131,115
| -39% | -$3.09M |
|
16
Thermo Fisher Scientific
TMO
$213B
| $7.66M | 0.66% |
68,800
-52,120
| -43% | -$5.18M |
|
17
Incyte
INCY
$23.3B
| $7.62M | 0.65% |
+150,418
| New | +$6.54M |
|
18
Morgan Stanley
MS
$338B
| $7.42M | 0.63% |
236,610
-25,450
| -10% | -$757K |
|
19
Boeing
BA
$165B
| $7.21M | 0.62% |
52,813
-72,907
| -58% | -$9.48M |
|
|
LIN
20
DELISTED
LIN MEDIA LLC CLASS A COM
LIN
| $7.15M | 0.61% |
248,886
-53,584
| -18% | -$1.35M |
|
|
UFS
21
DELISTED
DOMTAR CORPORATION (New)
UFS
| $6.79M | 0.58% |
143,840
+30,640
| +27% | +$1.33M |
|
22
Elevance Health
ELV
$82.3B
| $6.71M | 0.57% |
+72,570
| New | +$6.45M |
|
|
RCPT
23
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
| $6.58M | 0.56% |
226,857
-108,904
| -32% | -$2.92M |
|
|
24
EOG Resources
EOG
$77.5B
| $6.48M | 0.55% |
77,224
-172,164
| -69% | -$14.8M |
|
25
WisdomTree Japan Hedged Equity Fund
DXJ
$7.17B
| $6.1M | 0.52% |
120,000
+59,000
| +97% | +$2.87M |
|
Similar funds
SSA
WIM
LCP
SAM
ACM
PPI
BSSFA
CPA
Wexford Capital's Q4 2013 Portfolio in Review
As of Q4 2013, Wexford Capital held 315 positions worth $1.17B, down 3.5% from $1.21B the previous quarter. Its ten largest holdings account for 64% of the portfolio.
Wexford Capital withdrew a net $200M in Q4 2013, closing 98 positions and reducing 60 holdings. Its most notable exit was ONYX PHARMACEUTICALS INC, an estimated $31.6M position sold in full.
By sector, the portfolio is most concentrated in Energy at 61% of assets, up from 57% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Wexford Capital opened a new position in American Airlines Group worth $22.4M.
- Wexford Capital's largest Q4 2013 buy was American Airlines Group: 889,086 shares worth $22.4M.
- Wexford Capital added most to Allergan plc in Q4 2013, an estimated $9.42M increase.
- Wexford Capital's biggest Q4 2013 reduction was Diamondback Energy, cutting an estimated $56.6M.
- Wexford Capital fully exited ONYX PHARMACEUTICALS INC in Q4 2013, selling an estimated $31.6M.
- Wexford Capital's ten largest holdings make up 64% of its $1.17B portfolio in Q4 2013.
- Wexford Capital opened 118 new positions and closed 98 in Q4 2013.
- Wexford Capital's portfolio value fell 3.5% quarter-over-quarter to $1.17B.
Based on Wexford Capital's 13F filing for Q4 2013, filed 14 Feb 2014.